Süleyman Hilmi İPEKÇİ — Prof.Dr.

Tıp Fakültesi · İç Hastalıkları Anabilim Dalı · Atlas Üniversitesi

50 yayın · 195 atıf · h-index 8

CAN the variants in the THADA and ADAMST9 genes be common risk factors for type 2 diabetes development and obesity, Molecular Biology Reports (2026)

Real-World Comparison of Short-Term Adverse Events, Treatment Persistence, and Efficacy of Semaglutide and Tirzepatide: A Nationwide Multicenter Study, Obesity Facts (2026)

Investigation of new biomarkers that can be used for the diagnosis of asymptomatic diabetic peripheral artery disease (PAD): Serum netrin-1 levels can be a potential biomarker for the diagnosis of PAD, DergiPark (Istanbul University) (2024)

Correction to: Protective effect of the rare variant rs13266634C/T of the SLC30A8 gene in the genetic background of the development of type 2 diabetes in Turkish population, International Journal of Diabetes in Developing Countries (2023)

Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study, The Journal of Clinical Endocrinology & Metabolism (2023)

Protective effect of the rare variant rs13266634C/T of the SLC30A8 gene in the genetic background of the development of type 2 diabetes in Turkish population, International Journal of Diabetes in Developing Countries (2023)

Assessment of Serum Galectin-3 Levels in Patients with Gestational Diabetes Mellitus, Journal of Diabetology (2023)

Effects of Carbohydrate and Fats in Turkish Patients with Type 2 Diabetes, Journal of Contemporary Medicine (2022)

Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients, Endocrine Regulations (2022)

Evaluation of Bone Turnover Markers Such as Osteoprotegerin, Sclerostin and Dickkopf-1 in Subclinical Hyperthyroidism, Indian Journal of Clinical Biochemistry (2022)